Structures by: Basavoju S.
Total: 33
C36H26BrClN6O2
C36H26BrClN6O2
New Journal of Chemistry (2019)
a=16.7974(6)Å b=8.9666(3)Å c=21.2412(8)Å
α=90° β=102.402(4)° γ=90°
C36H26Cl2N6O2
C36H26Cl2N6O2
New Journal of Chemistry (2019)
a=33.0853(18)Å b=8.8295(6)Å c=21.2489(19)Å
α=90° β=90.410(7)° γ=90°
2(C28H24BrN2O2S),3(C2H4O2),BrH,Br
2(C28H24BrN2O2S),3(C2H4O2),BrH,Br
RSC Advances (2014) 4, 44 22866
a=12.9000(12)Å b=14.6334(14)Å c=16.9440(16)Å
α=87.112(2)° β=84.698(2)° γ=74.154(2)°
Acesulfame Form I
C4H5NO4S
Chemical Communications (2010) 46, 20 3562-3564
a=7.4940(15)Å b=11.784(2)Å c=15.238(3)Å
α=90.00° β=101.36(3)° γ=90.00°
Acesulfame Form II
C4H5NO4S
Chemical Communications (2010) 46, 20 3562-3564
a=6.3310(2)Å b=7.4720(3)Å c=7.7150(3)Å
α=62.5460(15)° β=73.1710(18)° γ=77.874(2)°
C24H22N4O11
C24H22N4O11
CrystEngComm (2012) 14, 15 5078
a=7.2120(6)Å b=27.7094(17)Å c=12.0909(9)Å
α=90.00° β=91.789(8)° γ=90.00°
Nitrofurantoin:citric acid cocrystal
C8H6N4O5,C6H8O7
CrystEngComm (2012) 14, 15 5078
a=13.444(1)Å b=11.480(1)Å c=12.434(1)Å
α=90.000° β=113.736(1)° γ=90.000°
Bis(4-nitrophenyl)diphenylmethane
C25H18N2O4
CrystEngComm (2004) 6, 25 120
a=7.5520(15)Å b=16.296(3)Å c=16.174(3)Å
α=90.00° β=98.71(3)° γ=90.00°
Tetrakis-(4-cyanophenyl)methane
C29H16N4
CrystEngComm (2004) 6, 25 120
a=9.782(1)Å b=11.907(2)Å c=20.242(3)Å
α=90.00° β=98.13(1)° γ=90.00°
Tetrakis-(4-cyanophenyl)methane-MeCN
C29H16N4
CrystEngComm (2004) 6, 25 120
a=15.413(3)Å b=17.607(3)Å c=18.504(3)Å
α=90.00° β=90.00° γ=90.00°
Bis(4-nitrophenyl)diphenylmethane-water
C75H58N6O14
CrystEngComm (2004) 6, 25 120
a=20.909(2)Å b=20.909(2)Å c=25.247(4)Å
α=90.00° β=90.00° γ=120.00°
Bis(4-nitrophenyl)diphenylmethane-THF
C78H54N6O16
CrystEngComm (2004) 6, 25 120
a=20.916(3)Å b=20.916(3)Å c=25.122(5)Å
α=90.00° β=90.00° γ=120.00°
6-chloro-2,4-dinitroaniline
C6H4ClN3O4
Chemical Communications (2005)
a=11.285(3)Å b=18.220(3)Å c=7.886(8)Å
α=90.00° β=90.44(4)° γ=90.00°
6-Chloro-2,4-dinitroanilene
C6H4ClN3O4
Chemical Communications (2005)
a=8.1619(18)Å b=3.6646(8)Å c=13.278(3)Å
α=90.00° β=91.310(3)° γ=90.00°
6-Chloro-2,4-dinitroanilene
C6H4ClN3O4
Chemical Communications (2005)
a=7.9465(12)Å b=8.917(3)Å c=12.980(4)Å
α=89.35(3)° β=85.575(19)° γ=63.978(15)°
2-(methylsulfanyl)nicotinic acid
C7H7NO2S
Acta Crystallographica Section E (2005) 61, 4 o822-o823
a=3.9834(10)Å b=25.373(7)Å c=7.465(2)Å
α=90.00° β=101.380(4)° γ=90.00°
1,3-bis(3-pyridyl)ureahydrate(3:4)
C11H10N40,4/3(H2O)
Crystal Growth & Design (2006) 6, 1 161
a=12.941(3)Å b=11.789(2)Å c=22.401(5)Å
α=90.00° β=101.37(3)° γ=90.00°
N,N'-bis(3-pyridyl)urea+succinicacid
C11H11N4O,C4H5O4
Crystal Growth & Design (2006) 6, 1 161
a=38.093(8)Å b=5.2820(11)Å c=16.428(3)Å
α=90.00° β=109.35(3)° γ=90.00°
N-(3-pyridyl)-N'-phenylurea
C12H11N3O
Crystal Growth & Design (2006) 6, 1 161
a=11.7789(13)Å b=9.4606(10)Å c=18.262(2)Å
α=90.00° β=90.00° γ=90.00°
N,N'-bis(3-pyridyl)urea+Fumaricacid+water
C11H11N4O,C4H3O4,H2O
Crystal Growth & Design (2006) 6, 1 161
a=7.404(2)Å b=8.068(4)Å c=13.562(3)Å
α=104.55(3)° β=98.02(2)° γ=95.52(3)°
1,3-bis(3-N-methylpyridinium)urea diiodide
C13H16N4O,2(I)
Crystal Growth & Design (2006) 6, 1 161
a=7.7439(15)Å b=10.464(2)Å c=10.683(2)Å
α=101.42(3)° β=100.55(3)° γ=99.28(3)°
1,3-bis(3-pyridyl)urea
C11H10N4O
Crystal Growth & Design (2006) 6, 1 161
a=13.707(3)Å b=7.0140(14)Å c=10.006(2)Å
α=90.00° β=90.00° γ=90.00°
1,3-bis(3-pyridyl)urea dihydrate
C11H10N4O,2(H2O)
Crystal Growth & Design (2006) 6, 1 161
a=6.8138(5)Å b=19.586(11)Å c=9.292(4)Å
α=90.00° β=101.24(3)° γ=90.00°
N,N'-bis(3-pyridyl-N-oxide)urea dihydrate
C11H10N4O3,H2O
Crystal Growth & Design (2006) 6, 1 161
a=7.9686(7)Å b=12.2243(11)Å c=24.538(2)Å
α=90.00° β=90.650(2)° γ=90.00°
Cis,cis-1,3,5-cyclohexanetricarboxylic acid - 4,4'-bipyridine - 1,2-bis(4-pyridyl)ethane
C9H12O6,C10H8N2,0.5(C12H12N2)
Crystal Growth & Design (2005) 5, 5 1683
a=33.167(7)Å b=9.954(2)Å c=14.988(3)Å
α=90.00° β=110.91(3)° γ=90.00°
Cis,cis-1,3,5-cyclohexanetricarboxylic acid - 1,2-bis(4-pyridyl)ethane - 1,4-bis(4-pyridyl)butane - p-xylene
(C9H12O6),(C12H12N2),0.5(C14H16N2),0.5(C8H10)
Crystal Growth & Design (2005) 5, 5 1683
a=5.7110(4)Å b=14.1003(10)Å c=18.3960(13)Å
α=86.1000(10)° β=84.5600(10)° γ=82.1230(10)°
Cis,cis-1,3,5-cyclohexanetricarboxylic acid - 1,2-bis(4-pyridyl-N-oxy)ethylene - 4,4'-bipyridine
C9H12O6,0.5(C12H10N2O2),0.5(C10H8N2)
Crystal Growth & Design (2005) 5, 5 1683
a=6.1002(12)Å b=12.531(3)Å c=25.138(5)Å
α=90.00° β=93.73(3)° γ=90.00°
Norfloxacin.isonicotinamide.CHCL3
C16H18FN3O3,C6H6N2O,CHCl3
Crystal Growth & Design (2006) 6, 12 2699
a=18.8749(7)Å b=14.6353(6)Å c=18.4094(4)Å
α=90.00° β=98.432(2)° γ=90.00°
Norfloxacinmalonate dihydrate
C16H19FN3O3,C3H3O4,2(H2O)
Crystal Growth & Design (2006) 6, 12 2699
a=8.2170(1)Å b=9.1380(2)Å c=13.8830(2)Å
α=90.3920(10)° β=91.0800(10)° γ=96.7710(10)°
Norfloxacinmaleate hydrate
C16H19FN3O3,C4H3O4,H2O
Crystal Growth & Design (2006) 6, 12 2699
a=7.0890(2)Å b=9.8742(3)Å c=14.5854(3)Å
α=96.457(2)° β=92.300(2)° γ=102.937(2)°
Norfloxacin (succinate)0.5 hydrate
C16H19FN3O3,0.5(C4H4O4),H2O
Crystal Growth & Design (2006) 6, 12 2699
a=6.8086(2)Å b=9.3743(3)Å c=15.5127(4)Å
α=93.690(2)° β=93.262(2)° γ=110.885(2)°
1,3-bis(3-pyridyl)ureadihydrate
C11H10N4O,2(H2O)
Crystal Growth & Design (2006) 6, 1 161
a=6.7932(8)Å b=19.560(2)Å c=9.2746(11)Å
α=90.00° β=101.260(2)° γ=90.00°
Norfloxacin
C16H18FN3O3
Crystal Growth & Design (2006) 6, 12 2699
a=4.3240(10)Å b=9.6350(10)Å c=18.0890(10)Å
α=78.514(10)° β=87.121(10)° γ=80.574(10)°